SOPHiA GENETICS SA Cash on Hand 2020-2025 | SOPH
SOPHiA GENETICS SA cash on hand from 2020 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
SOPHiA GENETICS SA Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $80 |
| 2023 | $123 |
| 2022 | $179 |
| 2021 | $265 |
| 2020 | $97 |
| 2019 | $18 |
|
SOPHiA GENETICS SA Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $82 |
| 2025-06-30 | $95 |
| 2025-03-31 | $69 |
| 2024-12-31 | $80 |
| 2024-09-30 | $96 |
| 2024-06-30 | $105 |
| 2024-03-31 | $104 |
| 2023-12-31 | $123 |
| 2023-09-30 | $133 |
| 2023-06-30 | $149 |
| 2023-03-31 | $162 |
| 2022-12-31 | $179 |
| 2022-09-30 | $189 |
| 2022-06-30 | $217 |
| 2022-03-31 | $244 |
| 2021-12-31 | $265 |
| 2021-09-30 | $281 |
| 2021-06-30 | $64 |
| 2021-03-31 | $78 |
| 2020-12-31 | $97 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.348B | $0.065B |
| SOPHiA GENETICS SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM(TM) Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. SOPHiA GENETICS SA is based in BOSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.335B | 44.34 |
| Tempus AI (TEM) | United States | $12.322B | 0.00 |
| Doximity (DOCS) | United States | $8.258B | 34.00 |
| Hims & Hers Health (HIMS) | United States | $7.362B | 59.89 |
| IRhythm Technologies (IRTC) | United States | $5.445B | 0.00 |
| Hinge Health (HNGE) | United States | $3.816B | 0.00 |
| Privia Health (PRVA) | United States | $2.881B | 180.15 |
| Inspire Medical Systems (INSP) | United States | $2.816B | 46.60 |
| Heartflow (HTFL) | United States | $2.707B | 0.00 |
| 10x Genomics (TXG) | United States | $2.506B | 0.00 |
| Omnicell (OMCL) | United States | $2.297B | 46.96 |
| Azenta (AZTA) | United States | $1.726B | 70.83 |
| Enovis (ENOV) | United States | $1.541B | 8.09 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.364B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.079B | 0.00 |
| Phreesia (PHR) | United States | $1.033B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.870B | 0.00 |
| Talkspace (TALK) | United States | $0.661B | 133.00 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.528B | 0.00 |
| Evolent Health (EVH) | United States | $0.463B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.387B | 0.00 |
| Carlsmed (CARL) | United States | $0.384B | 0.00 |
| TruBridge (TBRG) | United States | $0.328B | 15.06 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.273B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.204B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.173B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 6.84 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| HeartBeam (BEAT) | United States | $0.088B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.046B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| 111 (YI) | China | $0.032B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |